Skip to content

Curemark to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

10 June, 2024

Rye Brook, NY, June 10, 2024 – Curemark, the global leader in autism research and development announced that CEO Dr. Joan Fallon will address the Goldman Sachs Annual Global Healthcare Conference, on June 12th, at 8:40 am at the Loews Miami Beach Hotel in Miami Beach, Florida.

About Curemark

Curemark is a private, clinical-stage biopharmaceutical company developing novel therapies for the treatment of serious neurodevelopmental and neurodegenerative disorders.  The company’s first-in-class, disorder-modifying therapy for autism is part of a proprietary technology platform yielding novel therapeutics that address a broad range of neurological indications. To learn more about Curemark, please visit www.curemark.com